. 2021 Mar 10;197(6):537–546. doi: 10.1007/s00066-021-01751-y

Table 1.

Summary of the experimental design

Treatment groups	Irr	THA	Number of samples
Treatment groups	Irr	THA	d1–15	d16–30	d60–360	Total
Non-irradiated control	None	None	75^a	75^a	66^b	216
Irradiation control	d0	None	75^a	75^a	66^b	216
THA1–15	d0	Daily d1–15	75^a	75^a	66^b	216
THA16–30	d0	Daily d16–30	None	75^a	66^b	141
THA150–180	d0	EOD 150–180	None	None	126^c	126

d day, THA thalidomide, Irr irradiation, EOD every other day (EOD)

^a5 samples per day

^b6 samples every 30 days

^c6 samples EOD d150–180 and 6 samples every 30 days d210–360